PODESTA GROUP, INC. for EISAI INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | — |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Financial Institutions/Investments/Securities FIN
Student Loan Auction Rate Securities (SLARS).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| LAUREN MADDOX | — |
Education EDU
Student Loan Auction Rate Securities (SLARS)
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| LAUREN MADDOX | — |
Health Issues HCR
Alzheimer's issues. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | — |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Taxation/Internal Revenue Code TAX
Branded prescription pharmaceutical fee under health care reform.
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN | — |
| SHARON COHEN | — |
| ANDREW KAUDERS | — |
Medicare/Medicaid MMM
Medicare coverage and reimbursement issues. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.